tada's Recent Posts
Title Rating Company Posted on ▲
Re: We need news on the status of the Third Eye loan.... 3 Resverlogix Corp. Jan 31, 2019 06:38PM
Re: My email to Sarah...the latest 4 Resverlogix Corp. Feb 01, 2019 02:41AM
Re: You're right 10bagr, you didn't sway me.... 3 Resverlogix Corp. Feb 01, 2019 03:03AM
Re: You're right 10bagr, you didn't sway me.... 3 Resverlogix Corp. Feb 01, 2019 02:46PM
Re: You're right 10bagr, you didn't sway me.... 2 Resverlogix Corp. Feb 01, 2019 03:13PM
Re: You're right 10bagr, you didn't sway me.... 3 Resverlogix Corp. Feb 01, 2019 03:34PM
Re: Back on board 2 Resverlogix Corp. Feb 01, 2019 03:46PM
Re: You're right 10bagr, you didn't sway me.... 7 Resverlogix Corp. Feb 01, 2019 04:49PM
Re: You're right 10bagr, you didn't sway me.... 2 Resverlogix Corp. Feb 02, 2019 02:40AM
Re: You're right 10bagr, you didn't sway me.... 3 Resverlogix Corp. Feb 02, 2019 07:36PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada. 6 Zenith Epigenetics Feb 03, 2019 04:01AM
Re: Another Date that is fast approaching 3 Resverlogix Corp. Feb 04, 2019 01:53AM
Re: Price of ROFR for USA 2 Resverlogix Corp. Feb 04, 2019 08:10AM
Re: Negotiating with HL.... 3 Resverlogix Corp. Feb 04, 2019 11:13AM
Re: The waiting game..... 2 Resverlogix Corp. Feb 04, 2019 03:21PM
Re: It Pays to Wait ...... 5 Resverlogix Corp. Feb 04, 2019 04:17PM
Re: The waiting game..... 2 Resverlogix Corp. Feb 04, 2019 04:23PM
Re: Higher in the US and Germany? 2 Resverlogix Corp. Feb 05, 2019 02:24AM
Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer 5 Zenith Epigenetics Feb 05, 2019 09:14PM
Re: AD/PD 2019 March 26-31, 2019 3 Resverlogix Corp. Feb 06, 2019 03:45AM